RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value (RAPT)
CUSIP: 75382E208
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 27,748,559
- Total 13F shares
- 13,622,837
- Share change
- -1,996,791
- Total reported value
- $351,333,277
- Put/Call ratio
- 3.3%
- Price per share
- $25.79
- Number of holders
- 60
- Value change
- +$19,237,487
- Number of buys
- 32
- Number of sells
- 24
Quarterly Holders Quick Answers
What is CUSIP 75382E208?
CUSIP 75382E208 identifies RAPT - RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75382E208:
Institutional Holders of RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value (RAPT) as of Q3 2025
As of 30 Sep 2025,
RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value (RAPT) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,622,837 shares.
The largest 10 holders included
TCG Crossover Management, LLC, Foresite Capital Management VI LLC, RTW INVESTMENTS, LP, ORBIMED ADVISORS LLC, BOONE CAPITAL MANAGEMENT LLC, Deep Track Capital, LP, VANGUARD GROUP INC, Nantahala Capital Management, LLC, Ikarian Capital, LLC, and Siren, L.L.C..
This page lists
60
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
45
Q3 2025 holders
60
Holder diff
15
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.